Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement)
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-019-4263-9
document
BACKGROUND: For the diagnosis of prosthetic joint infection, real evidence-based guidelines to aid clinicians in choosing the most accurate diagnostic strategy are lacking. AIM AND METHODS: To address this need, we performed a multidisciplinary systematic review of relevant nuclear medicine, radiological, orthopaedic, infectious, and microbiological literature to define the diagnostic accuracy of each diagnostic technique and to address and provide evidence-based answers on uniform statements for each topic that was found to be important to develop a commonly agreed upon diagnostic flowchart. RESULTS AND CONCLUSION: The approach used...
Alberto Signore, L. M. Sconfienza, Olivier Borens, Andor W.J.M. Glaudemans, V. Cassar-Pullicino, A. Trampuz, Heinz Winkler, Olivier Gheysens, Filip M. Vanhoenacker, N Petrosillo, Paul C. Jutte
The diagnostic accuracy of F-18-FDG PET/CT in diagnosing fracture-related infections
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-018-4218-6
document
PURPOSE: 18F-Fluorodeoxyglucose positron emission tomography (18F-FDG PET/CT) is frequently used to diagnose fracture-related infections (FRIs), but its diagnostic performance in this field is still unknown. The aims of this study were: (1) to assess the diagnostic performance of qualitative assessment of 18F-FDG PET/CT scans in diagnosing FRI, (2) to establish the diagnostic performance of standardized uptake values (SUVs) extracted from 18F-FDG PET/CT scans and to determine their associated optimal cut-off values, and (3) to identify variables that predict a false-positive (FP) or false-negative (FN) 18F-FDG PET/CT result. METHODS:...
Justin V. C. Lemans, Monique G. G. Hobbelink, Frank F. A. Ijpma, Joost D. J. Plate, Janna van den Kieboom, Paul Bosch, Luke P. H. Leenen, Moyo C. Kruyt, Andor W. J. M. Glaudemans, Geertje A. M. Govaert
Early F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide.
Published in: Journal of Clinical Oncology
Access to document
10.1200/JCO.2019.37.7_suppl.232
Hilde Hoving, Selma Palthe, Marleen Vallinga, Rutger Dost, Jourik A. Gietema, Inez Antunes, Erik F. J. De Vries, Andor Glaudemans, Igle Jan de Jong
Towards consensus in acquisition and image analysis of PET and SPECT in the assessment of cardiac sympathetic innervation: a mini-review: a mini-review
Published in: Clinical and Translational Imaging
Access to document
10.1007/s40336-018-00309-w
document
In the rapidly evolving field of nuclear medicine, imaging cardiac sympathetic innervation using both conventional nuclear medicine and PET tracers is a small but growing field of interest. Recent larger clinical trials have underlined the importance of imaging cardiac sympathetic innervation as well as the consequences of low regional tracer accumulation for patient outcomes. New developments have resulted in the introduction of novel PET tracers with high clinical potential, especially for imaging centers without an on-site cyclotron. Despite the generated guidelines, especially on MIBG scintigraphy, widespread compliance with...
Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer
Published in: Cancer Research
Access to document
10.1158/1538-7445.SABCS18-PD4-09
B. Eisses, L. Angus, B. van der Vegt, A. M. Sieuwerts, J. Kraan, J. W. Martens, A. W. Glaudemans, A. H. Brouwers, O. S. Hoekstra, W. Oyen, J. Emmering, S. Gerritse, C. W. Menke-van der Houven van Oordt, E. Boon, C. M. van Herpen, A. Jager, S. Sleijfer, E. G. de Vries, C. P. Schröder